Minnesota Cancer Moonshot Summit
Vice President Joe Biden is convening a national Cancer Moonshot Summit June 29, which will spark cancer discussions in communities across the United States. Masonic Cancer Center, University of Minnesota and University of Minnesota Health are hosting the conversation locally. We are inviting researchers, oncologists, care providers, philanthropists, data and tech experts, advocates, patients and their families, and survivors to convene under the national charge to double the rate of progress toward a cure. Biden will address the summit via live stream as part of the program.
Wednesday, June 29, 2016 11:00 a.m.-4 p.m.
University of Minnesota-Twin Cities; McNamara Alumni Center - 200 Oak St. S.E., Minneapolis, MN 55445
Visit the MN Cancer Moonshot Summit on Facebook
Join our conversation on Twitter: #MNMoonshot
University of Minnesota Health Hosts
David Murphy, Fairview Health Services Board Chair and CEO, Co-President of M Health
Bobbi Daniels, M.D., University of Minnesota Physicians CEO, Co-President of M Health, Vice Dean for Clinical Affairs, University of Minnesota Medical School
Edward Greeno, M.D., Medical Director of Masonic Cancer Clinic; Executive Medical Director, Oncology Service Line of M Health, Masonic Cancer Center Executive Committee, Professor of Medicine, Division of Hematology, Oncology and Transplantation
Masonic Cancer Center Host
Brooks Jackson, M.D., M.B.A., Vice President for Health Sciences and Dean of the Medical School, University of Minnesota
Registration, light lunch and networking
Welcome and Introductions
Eric Neetenbeek, CEO of Minnesota Masonic Charities
Eric Kaler, Ph.D., President of the University of Minnesota
What is the Minnesota Cancer Moonshot?
Brooks Jackson, M.D., M.B.A., Dean of the University of Minnesota Medical School, Vice President of the Academic Health Cente
Survivor, Advocate, Philanthropist - A Combined Perspective
Ruth Bachman, Chair of the Masonic Cancer Center Community Advisory Board, Secretary and Treasurer of the Minnesota Cancer Alliance Steering Committee, cancer survivor, philanthropist
Cancer Prevention Panel
Facilitator: Dorothy Hatsukami, Ph.D., Associate Director, Cancer Prevention and Control, Masonic Cancer Center, Forster Family Chair in Cancer Prevention, Professor, Department of Psychiatry
In this panel, our experts will highlight the importance of basic science discoveries to the science of cancer prevention, the challenges of effectively disseminating the research findings to change behaviors, how prevention research and dissemination have not addressed health disparities in minority communities, and how public policy can influence choices to avoid cancer.
Panelists: Bruce Alexander, Ph.D., Head, Division of Environmental Health Sciences; UMN School of Public Health; Ann Bode, Ph.D., Associate Director, The Hormel Institute, Professor, Cancer Biomarkers & Drug Resistance and Cellular and Molecular Biology; Kris Rhodes, Executive Director, American Indian Cancer Foundation; MN State Senator Sandra L. Pappas (DFL - District 65), President of the Senate; Kenneth Bence, M.B.A., M.H.A., Director of Public Health, State Public Programs division of Medica; Chair of the Steering Committee, Minnesota Cancer Alliance Steering Committee; Prasad Iyer, M.D., Professor of Medicine, Gastroenterology and Hepatology, Mayo Clinic Cancer Center
Beyond Chemo & Radiation: Using the immune system, vaccines, and viruses to beat cancer
Facilitator: Jeffrey Miller, M.D., Deputy Director, Masonic Cancer Center, Professor of Medicine, Roger L. and Lynn C. Headrick Chair in Cancer Therapeutics, Division of Hematology, Oncology, and Transplantation
What’s next? The experts will discuss the latest research that is already being used in the clinic including viral therapy, vaccines to immunize against cancer-causing viruses, and immunotherapy treatments that are working for kids with cancer.
Panelists: Frank Ondrey, M.D., Ph.D., Program co-Director for Carcinogenesis & Chemoprevention, Masonic Cancer Center (Human Papiloma Virus), Associate Professor, Department of Otoloaryngology, Head and Neck Surgery; Michael Verneris, M.D., Associate Professor of Pediatrics, Masonic Cancer Center (Pediatric Immunotherapy); Larry Pease, Ph.D., Professor of Immunology, Professor of Biochemistry and Molecular Biology, Cancer Immunology and Immunotherapy Program Lead, Mayo Clinic Cancer Center (Immunotherapy); Manish Patel, D.O., Assistant Professor of Medicine, Masonic Cancer Center (Viral Therapy), James Robinson, Ph.D., The Hormel Institute, Assistant Professor and Section Leader, Cell Signaling and Tumorigenesis
Clinical Trials & Patient Advocacy
Facilitator: Edward Greeno, M.D., Medical Director, Masonic Cancer Clinic; Executive Medical Director, Oncology Service Line, M Health; Professor, Department of Medicine, Division of Hematology, Oncology and Transplantation, Masonic Cancer Executive Committee
A research breakthrough is only a theoretical win until it is proven to be effective in the prevention or treatment of humankind’s cancer. Too few trials are opened, access to care issues arise, the perception of trials remains negative, and there is an unresolved tension between privacy of electronic medical records and the potential of big data integration to find patterns and potential personalized treatment paths.
Panelists: Richard Peterson, M.D., HealthPartners Neuro Oncologist and participating member of Metro-Minnesota Community Oncology Research Consortium; Judy Erdahl, Patient, Advocate and Philanthropist, Co-founder, Team Judy; Thomas Witzig, M.D., Professor, Department of Medicine, Deputy Director for Clinical Research, Mayo Clinic Cancer Center; Susan Wolf, J.D., Professor, Department of Medicine; McKnight Presidential Professor of Law, Medicine & Public Policy; Chair of the Consortium on Law and Values in Health, Environment & the Life Sciences; Scott Nelson, Patient and Research Advocate
Vice President Joe Biden’s Remarks from Washington, D.C.
Amy Klobuchar, U.S. Senator from Minnesota
Al Franken, U.S. Senator from Minnesota
Closing Discussion and Charge
Edward Greeno, M.D., Medical Director, Masonic Cancer Clinic; Executive Medical Director, Oncology Service Line, M Health; Professor, Department of Medicine, Division of Hematology, Oncology and Transplantation, Masonic Cancer Executive Committee
McNamara Alumni Center, 200 Oak Street S.E., Minneapolis, MN 55455